TR201905694T4 - Aripiprazol ön ilaç bileşimleri. - Google Patents
Aripiprazol ön ilaç bileşimleri. Download PDFInfo
- Publication number
- TR201905694T4 TR201905694T4 TR2019/05694T TR201905694T TR201905694T4 TR 201905694 T4 TR201905694 T4 TR 201905694T4 TR 2019/05694 T TR2019/05694 T TR 2019/05694T TR 201905694 T TR201905694 T TR 201905694T TR 201905694 T4 TR201905694 T4 TR 201905694T4
- Authority
- TR
- Turkey
- Prior art keywords
- aripiprazole prodrug
- surface stabilizer
- prodrug
- aripiprazole
- particles
- Prior art date
Links
- 229940002612 prodrug Drugs 0.000 title abstract 5
- 239000000651 prodrug Substances 0.000 title abstract 5
- CEUORZQYGODEFX-UHFFFAOYSA-N Aripirazole Chemical compound ClC1=CC=CC(N2CCN(CCCCOC=3C=C4NC(=O)CCC4=CC=3)CC2)=C1Cl CEUORZQYGODEFX-UHFFFAOYSA-N 0.000 title abstract 4
- 229960004372 aripiprazole Drugs 0.000 title abstract 4
- 239000000203 mixture Substances 0.000 title abstract 4
- 239000002245 particle Substances 0.000 abstract 3
- 239000003381 stabilizer Substances 0.000 abstract 3
- 238000004090 dissolution Methods 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Quinoline Compounds (AREA)
Abstract
(a) 1000 nm'den daha az bir hacme dayalı partikül boyutuna (Dv50) sahip bir aripiprazol ön ilacına ait bir partikül popülasyonunu ve (b) aripiprazol ön ilacı partiküllerinin yüzeyinde adsorbe edilen bir adsorbe bileşen ve aripiprazol ön ilacın çözünmesi için mevcut bir serbest bileşen içeren en az bir yüzey stabilizatörünü içeren bir bileşim açıklanmaktadır. Yüzey stabilizatörünün ön ilaca oranı, bir giriş formülasyonu üretilmesi amaçlarıyla serbest yüzey stabilizatörünün optimal niceliğini sağlamaktadır. Ayrıca yukarıda bahsedilen bileşimi kullanan tedavi yöntemleri açıklanmaktadır.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201462038665P | 2014-08-18 | 2014-08-18 | |
EP14181328 | 2014-08-18 |
Publications (1)
Publication Number | Publication Date |
---|---|
TR201905694T4 true TR201905694T4 (tr) | 2019-05-21 |
Family
ID=53872058
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TR2019/05694T TR201905694T4 (tr) | 2014-08-18 | 2015-08-17 | Aripiprazol ön ilaç bileşimleri. |
Country Status (9)
Country | Link |
---|---|
JP (2) | JP6826167B2 (tr) |
CY (1) | CY1121594T1 (tr) |
DK (1) | DK3182958T4 (tr) |
ES (1) | ES2721270T5 (tr) |
HR (1) | HRP20190642T2 (tr) |
HU (1) | HUE043169T2 (tr) |
LT (2) | LT3508196T (tr) |
PT (1) | PT3182958T (tr) |
TR (1) | TR201905694T4 (tr) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
LT3508196T (lt) * | 2014-08-18 | 2021-09-10 | Alkermes Pharma Ireland Limited | Aripiprazolo provaisto kompozicijos |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3508196B1 (en) * | 2014-08-18 | 2021-07-14 | Alkermes Pharma Ireland Limited | Aripiprazole prodrug compositions |
LT3508196T (lt) * | 2014-08-18 | 2021-09-10 | Alkermes Pharma Ireland Limited | Aripiprazolo provaisto kompozicijos |
-
2015
- 2015-08-17 LT LTEP19154013.7T patent/LT3508196T/lt unknown
- 2015-08-17 DK DK15750750.0T patent/DK3182958T4/da active
- 2015-08-17 PT PT15750750T patent/PT3182958T/pt unknown
- 2015-08-17 HR HRP20190642TT patent/HRP20190642T2/hr unknown
- 2015-08-17 TR TR2019/05694T patent/TR201905694T4/tr unknown
- 2015-08-17 ES ES15750750T patent/ES2721270T5/es active Active
- 2015-08-17 LT LTEP15750750.0T patent/LT3182958T/lt unknown
- 2015-08-17 HU HUE15750750A patent/HUE043169T2/hu unknown
-
2019
- 2019-04-19 CY CY20191100430T patent/CY1121594T1/el unknown
- 2019-08-07 JP JP2019145176A patent/JP6826167B2/ja active Active
-
2021
- 2021-01-14 JP JP2021004441A patent/JP7157830B2/ja active Active
Also Published As
Publication number | Publication date |
---|---|
DK3182958T4 (da) | 2022-07-04 |
HRP20190642T1 (hr) | 2019-05-31 |
JP7157830B2 (ja) | 2022-10-20 |
ES2721270T3 (es) | 2019-07-30 |
RU2019134055A (ru) | 2020-02-03 |
HRP20190642T2 (hr) | 2022-07-08 |
LT3182958T (lt) | 2019-06-25 |
ES2721270T5 (es) | 2022-07-21 |
JP2020007316A (ja) | 2020-01-16 |
PT3182958T (pt) | 2019-05-23 |
CY1121594T1 (el) | 2020-05-29 |
HUE043169T2 (hu) | 2019-08-28 |
JP6826167B2 (ja) | 2021-02-03 |
LT3508196T (lt) | 2021-09-10 |
JP2021059604A (ja) | 2021-04-15 |
HRP20190642T4 (hr) | 2022-06-24 |
DK3182958T3 (da) | 2019-05-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2023000745A (es) | Composiciones para usarse en el suministro de agentes biomacromoleculares. | |
PH12018501226A1 (en) | Methods for treating huntingtons disease | |
PH12017501956A1 (en) | Compositions of obeticholic acid and methods of use | |
BR112015023629A2 (pt) | formulação de acetato de abiraterona | |
WO2017042607A3 (en) | Compositions comprising meloxicam-cyclodextrin inclusion complexes and methods of treating acute pain | |
EP3458074A4 (en) | COMPOSITIONS FOR DISPENSING TRNA NANOPARTICLES AND METHOD FOR USE THEREOF | |
WO2015160641A3 (en) | Compounds useful as immunomodulators | |
MX2015011984A (es) | Inhibidores de bromodominio de dihidro-pirrolopiridinona. | |
MX2019015744A (es) | Composiciones farmaceuticas. | |
NZ767204A (en) | Aripiprazole prodrug compositions | |
MX2016003660A (es) | Conjugados de partícula similar a virus para el diagnóstico y tratamiento de tumores. | |
MX2015011783A (es) | Metodos para tratar tumores solidos pediatricos. | |
NZ723860A (en) | Pharmaceutical compositions of therapeutically active compounds and their uses | |
EP3686184A3 (en) | Ionizable compounds and compositions and uses thereof | |
EP3898942A4 (en) | NANOPARTICLE COMPOSITIONS FOR EFFICIENT NUCLEIC ACID DELIVERY AND METHODS OF MAKING AND USE THEREOF | |
PH12017500098A1 (en) | Suspension compositions of cyclosporin a for subconjunctival and periocular injection | |
PH12017500451A1 (en) | Crystalline forms of 6-((6,7-dimethoxyquinazolin-4-yl) oxy)-n, 2-dimethylbenzofuran -3- carboxamide | |
MX2017006813A (es) | Composicion farmaceutica, preparacion y usos de la misma. | |
MX2021010595A (es) | Composicion farmaceutica, preparacion y usos de la misma. | |
MY183106A (en) | Fine dry particulate retinoid active agent compostions and topical formulations including the same | |
MX2019004580A (es) | Formulaciones farmaceuticas y metodos para prepararlas. | |
PH12016501434A1 (en) | Compositions for use in the treatment of allergic conditions | |
MX2016002930A (es) | Moduladores del receptor x hepatico (lxr). | |
IN2013MU01177A (tr) | ||
TR201905694T4 (tr) | Aripiprazol ön ilaç bileşimleri. |